Miles Heide
2024 CBB Stats
PTS
4.0
REB
3.6
AST
0.6
STL
0.3
BLK
0.3
ROS Projections
Promoted to starting role
Heide is in the starting lineup for Tuesday's game against New Mexico, Geoff Grammer of the Albuquerque Journal reports.
ANALYSIS
SDSU will be without Magoon Gwath due to a knee problem, meaning Heide will step in as his replacement. This will be Heide's fourth start of the campaign. In his previous three, he averaged 4.7 points, 3.3 rebounds and 0.3 steals across 22.7 minutes per contest.
SDSU will be without Magoon Gwath due to a knee problem, meaning Heide will step in as his replacement. This will be Heide's fourth start of the campaign. In his previous three, he averaged 4.7 points, 3.3 rebounds and 0.3 steals across 22.7 minutes per contest.
College Basketball Stats
Loading CBB Stats...
2024
2023
2024 CBB Game Log
Loading Game Log...
2024 CBB Split Stats
Loading CBB Stats...
Aztecs Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
More Fantasy News
Available Saturday
Heide (illness) is available for the Aztecs against New Mexico on Saturday, Jon Rothstein of CBS Sports reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Practices Thursday
Heide (illness) returned to practice this week and is traveling with the Aztecs ahead of Saturday's matchup with New Mexico, Mark Zeigler of The San Diego Union-Tribune reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
DNP vs. Air Force
Heide (illness) did not play during SDSU's 67-38 win Wednesday against the Air Force, according to Mark Zeigler of The San Diego Union-Tribune.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Gets starting nod Saturday
Heide will start against UC Irvine on Saturday, Mark Zeigler of the San Diego Union-Tribune reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.